Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Integra Lifesciences Holdings (IART) Return on Capital Employed (2016 - 2026)

Integra Lifesciences Holdings' Return on Capital Employed history spans 16 years, with the latest figure at 15.57% for Q4 2025.

  • On a quarterly basis, Return on Capital Employed fell 1648.0% to 15.57% in Q4 2025 year-over-year; TTM through Dec 2025 was 15.57%, a 1648.0% decrease, with the full-year FY2025 number at 14.67%, down 1562.0% from a year prior.
  • Return on Capital Employed hit 15.57% in Q4 2025 for Integra Lifesciences Holdings, down from 14.6% in the prior quarter.
  • Over the last five years, Return on Capital Employed for IART hit a ceiling of 6.77% in Q4 2022 and a floor of 17.09% in Q2 2025.
  • Historically, Return on Capital Employed has averaged 1.29% across 5 years, with a median of 4.48% in 2021.
  • Biggest five-year swings in Return on Capital Employed: soared 389bps in 2021 and later crashed -1878bps in 2025.
  • Tracing IART's Return on Capital Employed over 5 years: stood at 5.74% in 2021, then rose by 18bps to 6.77% in 2022, then plummeted by -52bps to 3.23% in 2023, then tumbled by -72bps to 0.91% in 2024, then crashed by -1815bps to 15.57% in 2025.
  • Business Quant data shows Return on Capital Employed for IART at 15.57% in Q4 2025, 14.6% in Q3 2025, and 17.09% in Q2 2025.